Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2025-08-20 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司独立董事候选人声明与承诺（宣建伟）
Regulatory Filings
2025-08-20 Chinese
科美诊断技术股份有限公司独立董事提名人声明与承诺（刘宁悦）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment regarding the nomination of an independent director candidate for the company's board. It details the qualifications, independence criteria, and compliance with regulatory requirements for the nominee. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically about director nomination and qualifications. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and does not indicate an announcement of a report publication or regulatory filing. Hence, the classification is MANG with high confidence.
2025-08-20 Chinese
科美诊断技术股份有限公司关于董事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from the board of directors of 科美诊断技术股份有限公司 regarding the completion of the board of directors' term and the nomination of candidates for the new board. It details the nomination and qualifications of both independent and non-independent director candidates, their resumes, and compliance with relevant laws and regulations. The document also mentions the upcoming shareholders' meeting to approve the new board. There is no financial data, earnings information, or audit content. The document is clearly about changes in the company's board of directors and management structure. Therefore, it fits the category of Board/Management Information (MANG). The document length is over 6000 characters, so it is not a brief announcement or a report publication notice. Confidence is high due to the detailed nature of director candidate information and the focus on board election.
2025-08-20 Chinese
上海市通力律师事务所关于科美诊断技术股份有限公司差异化分红事项之专项法律意见书
Regulatory Filings
2025-06-05 Chinese
科美诊断技术股份有限公司2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an "Annual Equity Distribution Implementation Announcement" for the year 2024 by 科美诊断技术股份有限公司. It details the dividend distribution plan approved at the 2024 annual shareholders meeting held on May 19, 2025. The document includes specific dividend amounts per share, relevant dates for record, ex-dividend, and payment, and tax treatment for different shareholder categories. It is an announcement of dividend distribution details rather than a full annual report or financial statement. The document length is 3593 characters, which is relatively short and focused on dividend distribution information. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2025-06-05 Chinese
科美诊断技术股份有限公司2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions passed at the 2024 Annual General Meeting (AGM) of 科美诊断技术股份有限公司. It details the meeting date, attendance, voting results on various proposals including the 2024 annual report, board and supervisory reports, financial statements, profit distribution plan, auditor appointment, and amendments to company governance documents. The document is a formal disclosure of voting results and meeting proceedings rather than the full annual report or financial statements themselves. It fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (5732 characters) and content confirm it is a detailed voting result announcement rather than a brief report publication notice or the report itself.
2025-05-19 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.